ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12496 recruiting trials
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)
👨⚕️ Pablo García Pavía, H.U. Puerta de Hierro, Majadahonda📍 31 sites📅 Started Sep 2023View details ↗
Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
👨⚕️ Benjamin Ellingson, PhD, University of California at Los Angeles📍 1 site📅 Started Sep 2023View details ↗
Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma
👨⚕️ lugui Qiu, MD, blood diseases hospital，chinese academy of medical sciences📍 1 site📅 Started Sep 2023View details ↗
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
👨⚕️ Joseph Rossano, MD, Children's Hospital of Philadelphia📍 6 sites📅 Started Sep 2023View details ↗
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
👨⚕️ Catherine THIEBLEMONT, Pr, Lymphoma Study Association📍 48 sites📅 Started Sep 2023View details ↗
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Enrolling by InvitationNCT06409039 ↗
POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
👨⚕️ Pharmacosmos Clinical and non-clinical Department, Pharmacosmos A/S📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT04990908 ↗
Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
RecruitingNCT06050057 ↗
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
👨⚕️ MUDr. Igor Hartmann Ph.D., Dpt. of Urology, University hospital Olomouc📍 1 site📅 Started Sep 2023View details ↗
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
👨⚕️ Katarina Stingl, Center for Ophthalmology, University of Tuebingen📍 1 site📅 Started Sep 2023View details ↗
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →